Act4cure Captab Pharmaceuticals Private Limited - Company Profile

It is a business services private limited company based in New Delhi, Delhi, India, established in 2023.
2023 New Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Act4cure Captab Pharmaceuticals Private Limited

Act4cure Captab Pharmaceuticals Private Limited, a struck off private limited company, was established on 11 October 2023 in New Delhi, Delhi, India. it holds CIN: U47721DL2023PTC421165. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Shweta Bhola (Director), Ajay Kumar Bhola (Director). It is based at S2/176 Shop-3,Gf B- Block, Old Mahavir Nagar, New Delhi, Delhi, 110018.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U47721DL2023PTC421165

  • Registration Number

    421165

  • Incorporation Date

    11 October 2023

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 2 Year, 4 Months
Company report

Act4cure Captab Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Act4cure Captab Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Act4cure Captab Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Shweta Bhola Director 11 Oct 2023 Current
Ajay Kumar Bhola Director 11 Oct 2023 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Act4Cure Captab Pharmaceuticals.

Enhance accessibility to Act4Cure Captab Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Act4Cure Captab Pharmaceuticals revenue growth over time
Act4Cure Captab Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Act4Cure Captab Pharmaceuticals?

Unlock access to Act4Cure Captab Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Act4Cure Captab Pharmaceuticals?

Unlock and access historical data on people associated with Act4Cure Captab Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Act4Cure Captab Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Act4Cure Captab Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Act4Cure Captab Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Shweta Bhola was appointed as a Director was appointed as a Director on 11 Oct 2023 & has been associated with this company since 2 years 4 months . was completed.

  • Director Appointment

    The activity Ajay Kumar Bhola was appointed as a Director was appointed as a Director on 11 Oct 2023 & has been associated with this company since 2 years 4 months . was completed.

  • Company Incorporation

    Progress on Act4Cure Captab Pharmaceuticals Private Limited was registered on 11 Oct 2023 with Roc Delhi & aged 2 years 4 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Act4cure Captab Pharmaceuticals Private Limited?

The CIN of Act4cure Captab Pharmaceuticals Private Limited is U47721DL2023PTC421165.

Where is Act4cure Captab Pharmaceuticals Private Limited headquartered?

Act4cure Captab Pharmaceuticals Private Limited is headquartered at S2/176 Shop-3,Gf B- Block, Old Mahavir Nagar, New Delhi, Delhi, 110018.

When was Act4cure Captab Pharmaceuticals Private Limited incorporated?

Act4cure Captab Pharmaceuticals Private Limited was incorporated on 11 October 2023.

Who are the current directors of Act4cure Captab Pharmaceuticals Private Limited?

The current directors of Act4cure Captab Pharmaceuticals Private Limited are

Is Act4cure Captab Pharmaceuticals Private Limited a listed company?

Act4cure Captab Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Act4cure Captab Pharmaceuticals Private Limited?

The authorized capital of Act4cure Captab Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available